A reduction in haemoglobin concentrations by > 4 g/ dl was observed in 30% of patients treated with Ribavirin and peginterferon alfa-2b and 37% of patients treated with Ribavirin + interferon alfa-2b.
Hemoglobiini kontsentratsiooni vähenemist > 4 g/ dl võrra täheldati 30% - l patsientidest, keda raviti ribaviriini ja peginterferooniga alfa- 2b ja 37% - l patsientidest, keda raviti ribaviriini + interferooniga alfa- 2b.